A SECRET WEAPON FOR LINK ALTERNATIF MBL77

Not all patients with CLL demand therapy. In spite of all new advances, the iwCLL however endorses watchful observation for sufferers with asymptomatic disease.86 This recommendation is based on a minimum of two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104